Severe adverse events MCID: 50 per 1000 · treating kidney stones
It is very uncertain whether tubeless PNL changes severe adverse events MCID: 50 per 1000 compared with standard PNL (very low certainty).
1 finding from 1 review
Postoperative pain (day 1) · treating kidney stones
1 finding from 1 review
Operating time · treating kidney stones
1 finding from 1 review
Length of hospital stay · treating kidney stones
1 finding from 1 review
Blood transfusion · treating kidney stones
It is very uncertain whether tubeless PNL changes blood transfusion MCID: 10 per 1000 compared with standard PNL (very low certainty).
1 finding from 1 review
Sepsis or fever MCID: 50 per 1000 · treating kidney stones
It is very uncertain whether tubeless PNL changes sepsis or fever MCID: 50 per 1000 compared with standard PNL (very low certainty).
1 finding from 1 review
Patient readmissions · treating kidney stones
It is very uncertain whether tubeless PNL changes readmission (first 30 days) MCID: 50 per 1000 compared with standard PNL (very low certainty).
1 finding from 1 review
Operating time · treating kidney stones
1 finding from 1 review
Length of hospital stay · treating kidney stones
1 finding from 1 review
Blood transfusion · treating kidney stones
It is very uncertain whether totally tubeless PNL changes blood transfusion MCID: 10 per 1000 compared with standard PNL (very low certainty).
1 finding from 1 review
Sepsis or fever MCID: 50 per 1000 · treating kidney stones
Totally tubeless PNL showed no clear difference in sepsis or fever MCID: 50 per 1000 compared with standard PNL (low certainty).
1 finding from 1 review
Patient readmissions · treating kidney stones
1 finding from 1 review
Severe adverse events MCID: 50 per 1000 · treating kidney stones
Totally tubeless PNL showed no clear difference in severe adverse events MCID: 50 per 1000 compared with standard PNL (low certainty).
1 finding from 1 review
Postoperative pain (day 1) · treating kidney stones
1 finding from 1 review